Brandon Shelley

Title: Innovations in Cryopreservation: The Work of Brandon Shelley

Introduction

Brandon Shelley is an accomplished inventor based in Los Angeles, CA. He has made significant contributions to the field of cryopreservation, particularly in the preservation of endothelial cells. His innovative work has the potential to advance medical research and therapeutic applications.

Latest Patents

Brandon Shelley holds a patent for "Methods and compositions for cryopreservation of endothelial cells." This patent addresses the challenges associated with freezing brain microvascular endothelial cells (BMECS), which are crucial for modeling the blood-brain barrier. The invention optimizes cell preparation, freezing media selection, and controlled freezing techniques to ensure the viability and functional properties of thawed cells. By achieving complete recovery of frozen cells, this innovation allows for the large-scale manufacturing, freezing, and distribution of BMECS.

Career Highlights

Brandon Shelley is affiliated with Cedars-Sinai Medical Center, where he continues to push the boundaries of biomedical research. His work has garnered attention for its potential applications in understanding and treating neurological conditions. With a focus on enhancing the viability of endothelial cells, he is contributing to advancements in regenerative medicine.

Collaborations

Brandon collaborates with notable colleagues such as Samuel Sances and Gad Vatine. Their combined expertise enhances the research efforts at Cedars-Sinai Medical Center, fostering an environment of innovation and discovery.

Conclusion

Brandon Shelley's contributions to cryopreservation represent a significant advancement in the field of biomedical research. His patented methods for preserving endothelial cells have the potential to revolutionize how researchers study the blood-brain barrier and develop new therapies.